Nicholas J. Butler, M.D.

Harvard Medical School

Assistant Professor of Ophthalmology

Research Summary

Dr. Butler conducts clinical research in the field of ocular immunology and uveitis, primarily focusing on the effectiveness of various therapies for ocular inflammatory disease and its complications. Additional areas of study include long-term outcomes of specific uveitides, infectious causes of uveitis, and inflammatory macular edema.

Download his CV for more information.

Education

1996: BA, English, Amherst College

2005: MD, McGill University Faculty of Medicine

Postgraduate Training

2006: Internship, The Caritas Carney Hospital, Tufts University School of Medicine

2009: Residency, Ophthalmology, Rhode Island Hospital, The Warren Alpert Medical School, Brown University

2011: Fellowship, Uveitis and Ocular Immunology, Casey Eye Institute, Oregon Health and Science University

Honors

2006: Award for Best Intern, The Caritas Carney Hospital, Tufts University School of Medicine

2009: Chief Resident, Rhode Island Hospital, The Warren Alpert Medical School, Brown University



Publications

Selected Publications

View his publications on PubMed or Google Scholar.

Ness SD, Butler NJ, Poulaki V. Bilateral Macular Choroidal Infarction as a Manifestation of Giant Cell Arteritis. Ophthalmic Surg Lasers Imaging Retina. 2018 Jul 1;49(7):540-543.

Butler NJ, Moradi A, Salek SS, Burkholder BM, Leung TG, Dunn JP, Thorne JE. Acute Retinal Necrosis: Presenting Characteristics and Clinical Outcomes in a Cohort of Polymerase Chain Reaction-Positive Patients. Am J Ophthalmol. 2017 Jul;179:179-189.

Paulus YM, Butler NJ. Spectral-Domain Optical Coherence Tomography, Wide-Field Photography, and Fundus Autofluorescence Correlation of Posterior Ophthalmomyiasis Interna. Ophthalmic Surg Lasers Imaging Retina. 2016 Jul 1;47(7):682-5.

Wang JC, Burkholder BM, Butler NJ. Topical difluprednate for the treatment of retinal vasculitis associated with birdshot chorioretinitis. Am J Ophthalmol Case Rep. 2016 Apr 29;3:22-24.

Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR, Rosenbaum JT. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014 Oct;121(10):1885-91.